Levels of CXCL13 and sICAM-1 correlate with disease activity score in patients with rheumatoid arthritis treated with tocilizumab
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2523-3106
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Levels of CXCL13 and sICAM-1 correlate with disease activity score in patients with rheumatoid arthritis treated with tocilizumab ; volume:59 ; number:1 ; day:4 ; month:12 ; year:2019 ; pages:1-8 ; date:12.2019
Advances in rheumatology ; 59, Heft 1 (4.12.2019), 1-8, 12.2019
- Urheber
-
Tuckwell, Katie
Gabay, Cem
Sornasse, Thierry
Laubender, Ruediger Paul
Wang, Jianmei
Townsend, Michael J.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s42358-019-0097-1
- URN
-
urn:nbn:de:101:1-2020033123324878339021
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tuckwell, Katie
- Gabay, Cem
- Sornasse, Thierry
- Laubender, Ruediger Paul
- Wang, Jianmei
- Townsend, Michael J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab
Tocilizumab Effects on Coagulation Factor XIII in Patients with Rheumatoid Arthritis
Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: a case series
Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics
Tocilizumab: A Review in Rheumatoid Arthritis
Circulating CD133+CD34+ progenitor cells inversely correlate with soluble ICAM-1 in early ischemic stroke patients
Evaluation of tocilizumab therapy in patients with rheumatoid arthritis based on FDG-PET/CT
Patterns of Prednisone Use in Patients with Rheumatoid Arthritis Initiating Treatment with Tocilizumab in Routine US Clinical Practice
Longitudinal immunomonitoring following Tocilizumab in rheumatoid arthritis
Retreatment efficacy and safety of tocilizumab in patients with rheumatoid arthritis in recurrence (RESTORE) study
P3.09: Treatment with Tocilizumab Improves Arterial Function in Rheumatoid Arthritis: A 6-Months Pilot Study
Concomitant Use of Statins in Tocilizumab-Treated Patients with Rheumatoid Arthritis: A Post Hoc Analysis
A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab
Tocilizumab Effects on Coagulation Factor XIII in Patients with Rheumatoid Arthritis
Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: a case series
Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics
Tocilizumab: A Review in Rheumatoid Arthritis
Circulating CD133+CD34+ progenitor cells inversely correlate with soluble ICAM-1 in early ischemic stroke patients
Evaluation of tocilizumab therapy in patients with rheumatoid arthritis based on FDG-PET/CT
Patterns of Prednisone Use in Patients with Rheumatoid Arthritis Initiating Treatment with Tocilizumab in Routine US Clinical Practice
Longitudinal immunomonitoring following Tocilizumab in rheumatoid arthritis
Retreatment efficacy and safety of tocilizumab in patients with rheumatoid arthritis in recurrence (RESTORE) study
P3.09: Treatment with Tocilizumab Improves Arterial Function in Rheumatoid Arthritis: A 6-Months Pilot Study
Concomitant Use of Statins in Tocilizumab-Treated Patients with Rheumatoid Arthritis: A Post Hoc Analysis
A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab
Tocilizumab Effects on Coagulation Factor XIII in Patients with Rheumatoid Arthritis
Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: a case series
Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics
Tocilizumab: A Review in Rheumatoid Arthritis
Circulating CD133+CD34+ progenitor cells inversely correlate with soluble ICAM-1 in early ischemic stroke patients
Evaluation of tocilizumab therapy in patients with rheumatoid arthritis based on FDG-PET/CT
Patterns of Prednisone Use in Patients with Rheumatoid Arthritis Initiating Treatment with Tocilizumab in Routine US Clinical Practice
Longitudinal immunomonitoring following Tocilizumab in rheumatoid arthritis
Retreatment efficacy and safety of tocilizumab in patients with rheumatoid arthritis in recurrence (RESTORE) study
P3.09: Treatment with Tocilizumab Improves Arterial Function in Rheumatoid Arthritis: A 6-Months Pilot Study